Parkinson's Disease, Neurodegenerative Diseases Mental and Behavioural Disorders Parkinson's Disease
Conditions
Interventions
Current interventions as of 09/09/2020:
This is prospective, pre-test/post-test, one-group study, with both quantitative and qualitative analysis. The study will investigate the effec
Sponsors
Colorado Parkinson Foundation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. BMI >18.5 2. Hoehn-Yahr Stages I-IV 3. Aged 50 to 85 years 4. Have received permission from their Primary Care Provider to participate in the study and, if diabetic, have received a written Insulin Sliding Scale to be used during the study 5. Are cognitively able to follow the dietary plan 6. Are able to read, speak, and understand English 7. Provide written informed consent to participate in the trial
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The course of Parkinson's disease measured using the Unified Parkinson's Disease Rating Scale (UPDRS) Parts 1 to 4 at baseline and 12 weeks 2. Anxiety measured using the Parkinson’s Anxiety Scale (PAS) at baseline and 12 weeks 3. Depression measured using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R-20) at baseline and 12 weeks 4. Lipid profile assessed through blood markers including HgA1C, Triglycerides, LDL, CRP, and HDL taken at baseline and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Mental, physical, and social quality of life assessed through qualitative analysis of these themes from audio-recorded structured interviews at baseline and 12 weeks | — |
Countries
United States of America
Contacts
Public ContactMelanie Tidman
Outcome results
None listed